Dimethyl Sulfoxide → Resveratrol Nicotinamide

HRID 82499

反応式

HRID 82499 の反応式
[C:1]1([CH:9]=[CH:10][C:11]2[CH:17]=[CH:16][C:14]([OH:15])=[CH:13][CH:12]=2)[CH:8]=[C:6]([OH:7])[CH:5]=[C:3]([OH:4])[CH:2]=1.CS(C)=O.CCN(C1C=CC2N=C3C(OC=2C=1)=CC(=O)C1C3=CC=CC=1)CC.[C:46]([NH2:54])(=[O:53])[C:47]1[CH:52]=[CH:51][CH:50]=[N:49][CH:48]=1>C(O)C>[C:1]1([CH:9]=[CH:10][C:11]2[CH:17]=[CH:16][C:14]([OH:15])=[CH:13][CH:12]=2)[CH:8]=[C:6]([OH:7])[CH:5]=[C:3]([OH:4])[CH:2]=1.[C:46]([NH2:54])(=[O:53])[C:47]1[CH:52]=[CH:51][CH:50]=[N:49][CH:48]=1

参加物

6

実験手順

Resveratrol (Indofine #024964) was dissolved in Ethanol or DMSO to a 10 mM stock solution. Resveratrol was added to 60 mm NGM agar dishes containing either OP50 or RNAi expressing bacteria (HT115) to a final concentration of 10 μm, 50 μm, and 100 μM. Nile Red was also added to plates to a final concentration of 0.05 μg/ml. Nicotinamide (Supelco #47865-U) was diluted in PBS including Nile Red and added to 60 mM dishes containing OP50 to a final concentration of 1 mM, 10 mM, or 100 mM.

後処理

  1. additioncontaining either OP50 or RNAi
  2. additionadded to 60 mM dishes
  3. additioncontaining OP50 to a final concentration of 1 mM, 10 mM, or 100 mM

出典と根拠

ORDレコード
ord-d63d9e947c4d41d99fb8ae169dba7c07
出典データセット
uspto-grants-2014_09
特許番号
US08846724B2

関連ノート

読み込み中…